Clinical Trials Directory

Trials / Completed

CompletedNCT02284282

Spinal Bupivacaine/Morphine in Laparoscopic Gastro-intestinal Surgery

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
56 (actual)
Sponsor
Maasstad Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to determine if a single spinal shot of morphine can decrease post-operative opioid-use, and thereby decrease opioid side-effects and lead to a quicker recovery after surgery.

Detailed description

We expect that in laparoscopic gastro-intestinal surgery, a single shot spinal with bupicavaine/morphine will result in a better analgesia in hte first 48 hours. Herby the patients will require less systemic opioids, which will decrease the side-effects. Furthermore, we expect the patients to recover quicker and show an earlier mobilisation and a shorter hospital stay. The objective of this study is to determine if a single spinal shot of morphine can decrease post-operative opioid-use, and thereby decrease opioid side-effects and lead to a quicker recovery after surgery.

Conditions

Interventions

TypeNameDescription
DRUGSpinal injection bupivacaine/morphineSpinal injection bupivacaine/morphine in laparoscopic surgery
DRUGsubcutaneum injection lidocaineplacebo injection

Timeline

Start date
2014-08-01
Primary completion
2016-11-01
Completion
2016-11-01
First posted
2014-11-06
Last updated
2018-08-08

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT02284282. Inclusion in this directory is not an endorsement.